There is growing recognition that cancer management in older patients should be based on the individual’s fitness and functional status, rather than age. For...
Radium-223 (Ra-223) dichloride is the first bone-targeted therapy for men with metastatic castration-resistant prostate cancer (mCRPC) with the ability to improve...